Outcomes following mepolizumab treatment discontinuation: real-world experience from an open-label trial

Overview of attention for article published in Allergy, Asthma & Clinical Immunology, June 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

twitter: 27 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 26 Dimensions

Readers on

mendeley: 25 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 1 public wall post.

Interasma, 12 Jun 2019

Outcomes following mepolizumab treatment discontinuation: real-world experience from an open-label trial

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.